Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
285 results
D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab
D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis
D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic
D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates
D1.390 - Long-term safety and efficacy of navenibart in participants with hereditary angioedema (HAE): Initial combined results from ALPHA-STAR and ALPHA-SOLAR
D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab
D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results
D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years
D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center
D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria
000103 - Characterization of Allergenic Proteins in Pine Nut: A Clinical Case Study
000167 - Omega 5 Gliadin positive presentation clinical profile
000239 - Staggered oral peanut challenge with regular consumption at home
000389 - Use of Dupilumab as Adjuvant Treatment in Oral Food Desensitization: A Case Report
000565 - Omalizumab for oral desensitization in children with cow's milk allergy
000762 - Transition: the future starts earlier
000854 - Allergen and Panallergen Sensitization Profile in Pediatric Eosinophilic Esophagitis Patients: a single centre experience
000868 - Prevalence of ltp syndrome among patients in Ukraine with respiratory allergy caused by sensitisation to wormwood ltp protein (Art v 3)
000878 - Kounis Syndrome induced by anaphylaxis after consuming hake
001422 - IgG3 antibodies specific for alpha-gal as a part of the cardiac risk profile of alpha-gal antibodies in patients living in an area with heavy tick infestation
Pagination
First page
First
Previous page
Previous
Page
1
Page
2
Page
3
Page
4
Current page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download